You're not saying that one-tailed tests aren't useful in research, but the "pros and cons" table in your original post does say that. That was my only objection.
For the record, I agree that a two-tailed test was required in this case.
- Forums
- ASX - By Stock
- RAC
- Ann: Race starts preclinical breast cancer study for Bisantrene
Ann: Race starts preclinical breast cancer study for Bisantrene, page-119
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.88 |
Change
0.025(1.35%) |
Mkt cap ! $319.4M |
Open | High | Low | Value | Volume |
$1.85 | $1.89 | $1.85 | $74.38K | 39.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18943 | $1.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.88 | 199 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18943 | 1.850 |
1 | 2500 | 1.830 |
2 | 987 | 1.820 |
8 | 16776 | 1.800 |
1 | 11000 | 1.780 |
Price($) | Vol. | No. |
---|---|---|
1.875 | 199 | 1 |
1.895 | 3000 | 1 |
1.940 | 5148 | 2 |
1.950 | 12000 | 1 |
1.990 | 4701 | 2 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |